Medpace Holdings, Inc. (01P)
Munich
Closed
Oct 9, 2026
Day's Range
545.0052 wk Range
343.90Overview - 01P - Medpace Holdings, Inc.
Key Statistics
Valuation
P/E (Trailing)
‪34.84‬
PEG Ratio
‪0.95‬
Price / Book
‪35.39‬
Profitability
Gross Margin
‪28.50%‬
Profit Margin
‪30.06%‬
Operating Margin
‪21.14%‬
Return on Assets
‪22.83%‬
Return on Equity
‪98.26%‬
Ownership
Shares Outstanding
27.91M
Price stats
50-Day Avg
‪520.60‬
200-Day Avg
‪448.90‬
Peers - 01P - Medpace Holdings, Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on Munich.
- 01PMunichMedpace Holdings, Inc.+17.36%52-week change34.85P/E (Trailing)‪30.06%‬Profit Margin
- 0MEMunichTwist Bioscience Corporation+85.89%52-week change-126.15P/E (Trailing)‪50.72%‬Profit Margin
- 1K9MunichCareDx, Inc.+75.91%52-week change-133.75P/E (Trailing)‪67.55%‬Profit Margin
- 5GHMunichGuardant Health Inc.+66.74%52-week change-46.63P/E (Trailing)‪64.46%‬Profit Margin
- ILUMunichIllumina Inc.+66.13%52-week change42.93P/E (Trailing)‪66.08%‬Profit Margin
- 04XMunichPersonalis Inc.+64.96%52-week change-15.92P/E (Trailing)‪22.65%‬Profit Margin
- NG9MunichNeoGenomics, Inc.+60.31%52-week change-20.24P/E (Trailing)‪43.21%‬Profit Margin
Profile Summary - 01P - Medpace Holdings, Inc.
About
Medpace Holdings, Inc. is a global clinical research organization that provides outsourced clinical development services for biotechnology, pharmaceutical, and medical device companies. Medpace supports the full clinical trial lifecycle, from Phase I through Phase IV, with services that include study design, project…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
